nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—Buclizine—Cetirizine—allergic rhinitis	0.208	0.524	CrCrCtD
Imatinib—Meclizine—Cetirizine—allergic rhinitis	0.189	0.476	CrCrCtD
Imatinib—SLC22A2—Diphenhydramine—allergic rhinitis	0.0297	0.0779	CbGbCtD
Imatinib—SLC22A1—Diphenhydramine—allergic rhinitis	0.0258	0.0677	CbGbCtD
Imatinib—PTGS1—Montelukast—allergic rhinitis	0.0202	0.0531	CbGbCtD
Imatinib—PTGS1—Diphenhydramine—allergic rhinitis	0.0202	0.0531	CbGbCtD
Imatinib—CYP2C19—Desloratadine—allergic rhinitis	0.0171	0.0448	CbGbCtD
Imatinib—CYP1A2—Desloratadine—allergic rhinitis	0.0157	0.0413	CbGbCtD
Imatinib—CYP2C9—Desloratadine—allergic rhinitis	0.0142	0.0372	CbGbCtD
Imatinib—ABCB1—Desloratadine—allergic rhinitis	0.0138	0.0361	CbGbCtD
Imatinib—CYP2D6—Desloratadine—allergic rhinitis	0.013	0.034	CbGbCtD
Imatinib—ABCG2—Hydrocortisone—allergic rhinitis	0.0122	0.032	CbGbCtD
Imatinib—CYP2C19—Loratadine—allergic rhinitis	0.0098	0.0257	CbGbCtD
Imatinib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0098	0.0257	CbGbCtD
Imatinib—CYP1A2—Diphenhydramine—allergic rhinitis	0.00904	0.0237	CbGbCtD
Imatinib—CYP3A7—Hydrocortisone—allergic rhinitis	0.00901	0.0236	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.00901	0.0236	CbGbCtD
Imatinib—CYP3A4—Flunisolide—allergic rhinitis	0.00825	0.0216	CbGbCtD
Imatinib—CYP2C9—Loratadine—allergic rhinitis	0.00815	0.0214	CbGbCtD
Imatinib—CYP2C9—Montelukast—allergic rhinitis	0.00815	0.0214	CbGbCtD
Imatinib—CYP2C9—Diphenhydramine—allergic rhinitis	0.00815	0.0214	CbGbCtD
Imatinib—ABCB1—Loratadine—allergic rhinitis	0.00791	0.0207	CbGbCtD
Imatinib—CYP3A4—Olopatadine—allergic rhinitis	0.00776	0.0203	CbGbCtD
Imatinib—ABCG2—Dexamethasone—allergic rhinitis	0.00759	0.0199	CbGbCtD
Imatinib—CYP2D6—Loratadine—allergic rhinitis	0.00745	0.0195	CbGbCtD
Imatinib—CYP2D6—Diphenhydramine—allergic rhinitis	0.00745	0.0195	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—allergic rhinitis	0.00723	0.019	CbGbCtD
Imatinib—CYP3A5—Hydrocortisone—allergic rhinitis	0.00676	0.0177	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.0056	0.0147	CbGbCtD
Imatinib—CYP3A7—Dexamethasone—allergic rhinitis	0.0056	0.0147	CbGbCtD
Imatinib—CYP3A4—Loratadine—allergic rhinitis	0.00474	0.0124	CbGbCtD
Imatinib—CYP3A4—Montelukast—allergic rhinitis	0.00474	0.0124	CbGbCtD
Imatinib—ABCB1—Betamethasone—allergic rhinitis	0.0047	0.0123	CbGbCtD
Imatinib—ABCB1—Prednisolone—allergic rhinitis	0.00464	0.0122	CbGbCtD
Imatinib—ABCB1—Hydrocortisone—allergic rhinitis	0.0044	0.0115	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.00433	0.0114	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—allergic rhinitis	0.0042	0.011	CbGbCtD
Imatinib—CA6—saliva—allergic rhinitis	0.00383	0.0699	CbGeAlD
Imatinib—CA6—ear—allergic rhinitis	0.0035	0.0639	CbGeAlD
Imatinib—CYP2C19—Dexamethasone—allergic rhinitis	0.00339	0.00889	CbGbCtD
Imatinib—CA3—ear—allergic rhinitis	0.00332	0.0605	CbGeAlD
Imatinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00328	0.00861	CbGbCtD
Imatinib—CYP2C9—Dexamethasone—allergic rhinitis	0.00282	0.00739	CbGbCtD
Imatinib—CYP3A4—Betamethasone—allergic rhinitis	0.00282	0.00739	CbGbCtD
Imatinib—CYP3A4—Prednisolone—allergic rhinitis	0.00278	0.00729	CbGbCtD
Imatinib—ABCB1—Dexamethasone—allergic rhinitis	0.00274	0.00718	CbGbCtD
Imatinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00264	0.00691	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—allergic rhinitis	0.00258	0.00676	CbGbCtD
Imatinib—ORM1—saliva—allergic rhinitis	0.00204	0.0372	CbGeAlD
Imatinib—CA6—exocrine gland—allergic rhinitis	0.00194	0.0354	CbGeAlD
Imatinib—ABCA3—respiratory system—allergic rhinitis	0.00176	0.0321	CbGeAlD
Imatinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00164	0.0043	CbGbCtD
Imatinib—ABCA3—eye—allergic rhinitis	0.0016	0.0293	CbGeAlD
Imatinib—DDR1—bronchus—allergic rhinitis	0.00133	0.0243	CbGeAlD
Imatinib—DDR1—trachea—allergic rhinitis	0.0012	0.0219	CbGeAlD
Imatinib—KIT—exocrine gland—allergic rhinitis	0.00113	0.0205	CbGeAlD
Imatinib—CA3—respiratory system—allergic rhinitis	0.000955	0.0174	CbGeAlD
Imatinib—ABCA3—lung—allergic rhinitis	0.000933	0.017	CbGeAlD
Imatinib—DDR1—lung—allergic rhinitis	0.000861	0.0157	CbGeAlD
Imatinib—PIP4K2C—bronchus—allergic rhinitis	0.000823	0.015	CbGeAlD
Imatinib—CA7—trachea—allergic rhinitis	0.00077	0.014	CbGeAlD
Imatinib—PIP4K2C—trachea—allergic rhinitis	0.000739	0.0135	CbGeAlD
Imatinib—PDGFRA—respiratory system—allergic rhinitis	0.000733	0.0134	CbGeAlD
Imatinib—LCK—bronchus—allergic rhinitis	0.000731	0.0133	CbGeAlD
Imatinib—CA12—respiratory system—allergic rhinitis	0.000677	0.0123	CbGeAlD
Imatinib—CA2—exocrine gland—allergic rhinitis	0.000667	0.0122	CbGeAlD
Imatinib—LCK—trachea—allergic rhinitis	0.000656	0.012	CbGeAlD
Imatinib—CSF1R—respiratory system—allergic rhinitis	0.000645	0.0118	CbGeAlD
Imatinib—CA12—eye—allergic rhinitis	0.000618	0.0113	CbGeAlD
Imatinib—NQO2—bronchus—allergic rhinitis	0.000605	0.011	CbGeAlD
Imatinib—CSF1R—eye—allergic rhinitis	0.00059	0.0108	CbGeAlD
Imatinib—KIT—respiratory system—allergic rhinitis	0.000586	0.0107	CbGeAlD
Imatinib—PDGFRB—respiratory system—allergic rhinitis	0.000572	0.0104	CbGeAlD
Imatinib—ABL2—lung—allergic rhinitis	0.000562	0.0102	CbGeAlD
Imatinib—NQO2—trachea—allergic rhinitis	0.000543	0.00991	CbGeAlD
Imatinib—PDGFRA—trachea—allergic rhinitis	0.000542	0.00988	CbGeAlD
Imatinib—SLC47A1—eye—allergic rhinitis	0.000538	0.00983	CbGeAlD
Imatinib—CA1—respiratory system—allergic rhinitis	0.000536	0.00978	CbGeAlD
Imatinib—PIP4K2C—lung—allergic rhinitis	0.000531	0.00969	CbGeAlD
Imatinib—CSF1R—bronchus—allergic rhinitis	0.000531	0.00969	CbGeAlD
Imatinib—PDGFRB—eye—allergic rhinitis	0.000523	0.00954	CbGeAlD
Imatinib—CSF1R—skin of body—allergic rhinitis	0.000513	0.00936	CbGeAlD
Imatinib—ABL1—respiratory system—allergic rhinitis	0.00051	0.00931	CbGeAlD
Imatinib—CA3—lung—allergic rhinitis	0.000507	0.00926	CbGeAlD
Imatinib—CA12—trachea—allergic rhinitis	0.0005	0.00912	CbGeAlD
Imatinib—KIT—epithelium—allergic rhinitis	0.00049	0.00894	CbGeAlD
Imatinib—CA1—eye—allergic rhinitis	0.00049	0.00894	CbGeAlD
Imatinib—KIT—bronchus—allergic rhinitis	0.000482	0.0088	CbGeAlD
Imatinib—PDGFRB—epithelium—allergic rhinitis	0.000478	0.00873	CbGeAlD
Imatinib—CSF1R—trachea—allergic rhinitis	0.000477	0.0087	CbGeAlD
Imatinib—LCK—lung—allergic rhinitis	0.000472	0.00861	CbGeAlD
Imatinib—PDGFRB—bronchus—allergic rhinitis	0.000471	0.0086	CbGeAlD
Imatinib—ABL1—eye—allergic rhinitis	0.000466	0.0085	CbGeAlD
Imatinib—KIT—skin of body—allergic rhinitis	0.000466	0.0085	CbGeAlD
Imatinib—PDGFRB—skin of body—allergic rhinitis	0.000455	0.0083	CbGeAlD
Imatinib—KIT—trachea—allergic rhinitis	0.000433	0.0079	CbGeAlD
Imatinib—PDGFRB—trachea—allergic rhinitis	0.000423	0.00772	CbGeAlD
Imatinib—ABL1—bronchus—allergic rhinitis	0.00042	0.00766	CbGeAlD
Imatinib—ABL1—skin of body—allergic rhinitis	0.000405	0.0074	CbGeAlD
Imatinib—NQO2—lung—allergic rhinitis	0.00039	0.00712	CbGeAlD
Imatinib—PDGFRA—lung—allergic rhinitis	0.000389	0.0071	CbGeAlD
Imatinib—ABL1—trachea—allergic rhinitis	0.000377	0.00688	CbGeAlD
Imatinib—CA12—lung—allergic rhinitis	0.000359	0.00656	CbGeAlD
Imatinib—CA2—respiratory system—allergic rhinitis	0.000347	0.00634	CbGeAlD
Imatinib—CSF1R—lung—allergic rhinitis	0.000343	0.00625	CbGeAlD
Imatinib—CA2—eye—allergic rhinitis	0.000317	0.00579	CbGeAlD
Imatinib—SLC47A1—lung—allergic rhinitis	0.000313	0.00571	CbGeAlD
Imatinib—KIT—lung—allergic rhinitis	0.000311	0.00568	CbGeAlD
Imatinib—CYP1A2—respiratory system—allergic rhinitis	0.00031	0.00565	CbGeAlD
Imatinib—PDGFRB—lung—allergic rhinitis	0.000304	0.00555	CbGeAlD
Imatinib—CYP3A5—respiratory system—allergic rhinitis	0.000299	0.00545	CbGeAlD
Imatinib—CA2—epithelium—allergic rhinitis	0.00029	0.0053	CbGeAlD
Imatinib—CA2—bronchus—allergic rhinitis	0.000286	0.00522	CbGeAlD
Imatinib—ORM1—lung—allergic rhinitis	0.000285	0.0052	CbGeAlD
Imatinib—CA1—lung—allergic rhinitis	0.000285	0.00519	CbGeAlD
Imatinib—CA2—skin of body—allergic rhinitis	0.000276	0.00504	CbGeAlD
Imatinib—ABL1—lung—allergic rhinitis	0.000271	0.00494	CbGeAlD
Imatinib—PTGS1—respiratory system—allergic rhinitis	0.000268	0.0049	CbGeAlD
Imatinib—CA2—trachea—allergic rhinitis	0.000257	0.00468	CbGeAlD
Imatinib—PTGS1—epithelium—allergic rhinitis	0.000224	0.00409	CbGeAlD
Imatinib—PTGS1—skin of body—allergic rhinitis	0.000213	0.00389	CbGeAlD
Imatinib—PTGS1—trachea—allergic rhinitis	0.000198	0.00362	CbGeAlD
Imatinib—CA2—lung—allergic rhinitis	0.000184	0.00337	CbGeAlD
Imatinib—ABCG2—lung—allergic rhinitis	0.000171	0.00312	CbGeAlD
Imatinib—CYP1A2—lung—allergic rhinitis	0.000164	0.003	CbGeAlD
Imatinib—ABCB1—respiratory system—allergic rhinitis	0.000159	0.00289	CbGeAlD
Imatinib—CYP3A5—lung—allergic rhinitis	0.000159	0.00289	CbGeAlD
Imatinib—PTGS1—lung—allergic rhinitis	0.000142	0.0026	CbGeAlD
Imatinib—ABCB1—epithelium—allergic rhinitis	0.000133	0.00242	CbGeAlD
Imatinib—ABCB1—trachea—allergic rhinitis	0.000117	0.00214	CbGeAlD
Imatinib—PDGFRA—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000109	0.00582	CbGpPWpGaD
Imatinib—PDGFRB—Validated targets of C-MYC transcriptional repression—SMAD3—allergic rhinitis	0.000107	0.00571	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—IL10—allergic rhinitis	0.000103	0.0055	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—IL4—allergic rhinitis	9.99e-05	0.00535	CbGpPWpGaD
Imatinib—LCK—TCR signaling—HLA-DQB1—allergic rhinitis	9.93e-05	0.00532	CbGpPWpGaD
Imatinib—ABL1—Regulation of Telomerase—SMAD3—allergic rhinitis	9.79e-05	0.00524	CbGpPWpGaD
Imatinib—LCK—The role of Nef in HIV-1 replication and disease pathogenesis—CD4—allergic rhinitis	9.67e-05	0.00518	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	9.29e-05	0.00497	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—IL4—allergic rhinitis	9e-05	0.00482	CbGpPWpGaD
Imatinib—LCK—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	8.86e-05	0.00475	CbGpPWpGaD
Imatinib—CA1—C-MYB transcription factor network—CD4—allergic rhinitis	8.75e-05	0.00469	CbGpPWpGaD
Imatinib—LCK—Generation of second messenger molecules—CD4—allergic rhinitis	8.69e-05	0.00465	CbGpPWpGaD
Imatinib—ABCB1—lung—allergic rhinitis	8.42e-05	0.00154	CbGeAlD
Imatinib—LCK—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	8.1e-05	0.00434	CbGpPWpGaD
Imatinib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	8e-05	0.00428	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—IL5—allergic rhinitis	7.91e-05	0.00423	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—ADIPOQ—allergic rhinitis	7.81e-05	0.00418	CbGpPWpGaD
Imatinib—LCK—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	7.56e-05	0.00404	CbGpPWpGaD
Imatinib—LCK—Glypican 1 network—TGFB1—allergic rhinitis	7.36e-05	0.00394	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	7.27e-05	0.00389	CbGpPWpGaD
Imatinib—LCK—Downstream TCR signaling—CD4—allergic rhinitis	7.13e-05	0.00381	CbGpPWpGaD
Imatinib—ABL1—Cell Cycle—SMAD3—allergic rhinitis	7.07e-05	0.00379	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—MS4A2—allergic rhinitis	6.95e-05	0.00372	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—SMAD3—allergic rhinitis	6.71e-05	0.00359	CbGpPWpGaD
Imatinib—LCK—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	6.67e-05	0.00357	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	6.6e-05	0.00353	CbGpPWpGaD
Imatinib—KIT—Differentiation Pathway—TGFB1—allergic rhinitis	6.59e-05	0.00353	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—MS4A2—allergic rhinitis	6.58e-05	0.00352	CbGpPWpGaD
Imatinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—allergic rhinitis	6.25e-05	0.00335	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—IL13—allergic rhinitis	6.22e-05	0.00333	CbGpPWpGaD
Imatinib—LCK—Downstream TCR signaling—NFKB1—allergic rhinitis	6.14e-05	0.00329	CbGpPWpGaD
Imatinib—KIT—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	6.09e-05	0.00326	CbGpPWpGaD
Imatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—allergic rhinitis	6.07e-05	0.00325	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—MS4A2—allergic rhinitis	5.92e-05	0.00317	CbGpPWpGaD
Imatinib—KIT—C-MYB transcription factor network—CD4—allergic rhinitis	5.87e-05	0.00314	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—MS4A2—allergic rhinitis	5.77e-05	0.00309	CbGpPWpGaD
Imatinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	5.76e-05	0.00308	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	5.72e-05	0.00306	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—SMAD3—allergic rhinitis	5.67e-05	0.00304	CbGpPWpGaD
Imatinib—LCK—TSLP Signaling Pathway—NFKB1—allergic rhinitis	5.5e-05	0.00295	CbGpPWpGaD
Imatinib—Mental disorder—Methylprednisolone—allergic rhinitis	5.38e-05	0.000362	CcSEcCtD
Imatinib—Erythema—Triamcinolone—allergic rhinitis	5.36e-05	0.000361	CcSEcCtD
Imatinib—Erythema—Methylprednisolone—allergic rhinitis	5.34e-05	0.00036	CcSEcCtD
Imatinib—Malnutrition—Methylprednisolone—allergic rhinitis	5.34e-05	0.00036	CcSEcCtD
Imatinib—LCK—TCR signaling—CD4—allergic rhinitis	5.33e-05	0.00285	CbGpPWpGaD
Imatinib—Angioedema—Prednisolone—allergic rhinitis	5.32e-05	0.000358	CcSEcCtD
Imatinib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	5.32e-05	0.00285	CbGpPWpGaD
Imatinib—Ill-defined disorder—Hydrocortisone—allergic rhinitis	5.28e-05	0.000355	CcSEcCtD
Imatinib—LCK—IL12-mediated signaling events—CD4—allergic rhinitis	5.25e-05	0.00281	CbGpPWpGaD
Imatinib—Malaise—Prednisolone—allergic rhinitis	5.25e-05	0.000354	CcSEcCtD
Imatinib—Dysgeusia—Triamcinolone—allergic rhinitis	5.25e-05	0.000353	CcSEcCtD
Imatinib—Vertigo—Prednisolone—allergic rhinitis	5.23e-05	0.000352	CcSEcCtD
Imatinib—Syncope—Prednisolone—allergic rhinitis	5.22e-05	0.000352	CcSEcCtD
Imatinib—Eye disorder—Dexamethasone—allergic rhinitis	5.22e-05	0.000351	CcSEcCtD
Imatinib—Eye disorder—Betamethasone—allergic rhinitis	5.22e-05	0.000351	CcSEcCtD
Imatinib—Angioedema—Hydrocortisone—allergic rhinitis	5.2e-05	0.00035	CcSEcCtD
Imatinib—Back pain—Triamcinolone—allergic rhinitis	5.18e-05	0.000349	CcSEcCtD
Imatinib—Malaise—Hydrocortisone—allergic rhinitis	5.13e-05	0.000345	CcSEcCtD
Imatinib—Loss of consciousness—Prednisolone—allergic rhinitis	5.12e-05	0.000345	CcSEcCtD
Imatinib—Vertigo—Hydrocortisone—allergic rhinitis	5.11e-05	0.000344	CcSEcCtD
Imatinib—Nausea—Montelukast—allergic rhinitis	5.11e-05	0.000344	CcSEcCtD
Imatinib—Syncope—Hydrocortisone—allergic rhinitis	5.1e-05	0.000344	CcSEcCtD
Imatinib—Angiopathy—Betamethasone—allergic rhinitis	5.07e-05	0.000341	CcSEcCtD
Imatinib—Angiopathy—Dexamethasone—allergic rhinitis	5.07e-05	0.000341	CcSEcCtD
Imatinib—Convulsion—Prednisolone—allergic rhinitis	5.05e-05	0.00034	CcSEcCtD
Imatinib—Hypertension—Prednisolone—allergic rhinitis	5.03e-05	0.000339	CcSEcCtD
Imatinib—Loss of consciousness—Hydrocortisone—allergic rhinitis	5e-05	0.000337	CcSEcCtD
Imatinib—Arrhythmia—Dexamethasone—allergic rhinitis	4.99e-05	0.000336	CcSEcCtD
Imatinib—Arrhythmia—Betamethasone—allergic rhinitis	4.99e-05	0.000336	CcSEcCtD
Imatinib—ALB—Folate Metabolism—IL4—allergic rhinitis	4.99e-05	0.00267	CbGpPWpGaD
Imatinib—ABL1—Regulation of Telomerase—NFKB1—allergic rhinitis	4.97e-05	0.00266	CbGpPWpGaD
Imatinib—Ill-defined disorder—Triamcinolone—allergic rhinitis	4.97e-05	0.000335	CcSEcCtD
Imatinib—Ill-defined disorder—Methylprednisolone—allergic rhinitis	4.96e-05	0.000334	CcSEcCtD
Imatinib—Alopecia—Dexamethasone—allergic rhinitis	4.93e-05	0.000332	CcSEcCtD
Imatinib—Alopecia—Betamethasone—allergic rhinitis	4.93e-05	0.000332	CcSEcCtD
Imatinib—Convulsion—Hydrocortisone—allergic rhinitis	4.93e-05	0.000332	CcSEcCtD
Imatinib—Hypertension—Hydrocortisone—allergic rhinitis	4.91e-05	0.000331	CcSEcCtD
Imatinib—Discomfort—Prednisolone—allergic rhinitis	4.9e-05	0.00033	CcSEcCtD
Imatinib—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	4.9e-05	0.00262	CbGpPWpGaD
Imatinib—Angioedema—Triamcinolone—allergic rhinitis	4.89e-05	0.00033	CcSEcCtD
Imatinib—Angioedema—Methylprednisolone—allergic rhinitis	4.88e-05	0.000329	CcSEcCtD
Imatinib—LCK—TCR signaling in naïve CD4+ T cells—CD4—allergic rhinitis	4.87e-05	0.00261	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	4.87e-05	0.00261	CbGpPWpGaD
Imatinib—Erythema—Betamethasone—allergic rhinitis	4.86e-05	0.000327	CcSEcCtD
Imatinib—Erythema—Dexamethasone—allergic rhinitis	4.86e-05	0.000327	CcSEcCtD
Imatinib—Myalgia—Hydrocortisone—allergic rhinitis	4.84e-05	0.000326	CcSEcCtD
Imatinib—Malaise—Triamcinolone—allergic rhinitis	4.83e-05	0.000325	CcSEcCtD
Imatinib—Anxiety—Hydrocortisone—allergic rhinitis	4.83e-05	0.000325	CcSEcCtD
Imatinib—Malaise—Methylprednisolone—allergic rhinitis	4.82e-05	0.000325	CcSEcCtD
Imatinib—Vertigo—Triamcinolone—allergic rhinitis	4.81e-05	0.000324	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	4.81e-05	0.000324	CcSEcCtD
Imatinib—Syncope—Triamcinolone—allergic rhinitis	4.8e-05	0.000323	CcSEcCtD
Imatinib—Vertigo—Methylprednisolone—allergic rhinitis	4.8e-05	0.000323	CcSEcCtD
Imatinib—Syncope—Methylprednisolone—allergic rhinitis	4.79e-05	0.000323	CcSEcCtD
Imatinib—Discomfort—Hydrocortisone—allergic rhinitis	4.79e-05	0.000322	CcSEcCtD
Imatinib—LCK—Costimulation by the CD28 family—CD4—allergic rhinitis	4.75e-05	0.00254	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—MS4A2—allergic rhinitis	4.75e-05	0.00254	CbGpPWpGaD
Imatinib—Anaphylactic shock—Prednisolone—allergic rhinitis	4.75e-05	0.00032	CcSEcCtD
Imatinib—Oedema—Prednisolone—allergic rhinitis	4.75e-05	0.00032	CcSEcCtD
Imatinib—Loss of consciousness—Triamcinolone—allergic rhinitis	4.71e-05	0.000317	CcSEcCtD
Imatinib—Loss of consciousness—Methylprednisolone—allergic rhinitis	4.7e-05	0.000316	CcSEcCtD
Imatinib—Shock—Prednisolone—allergic rhinitis	4.68e-05	0.000315	CcSEcCtD
Imatinib—Cough—Triamcinolone—allergic rhinitis	4.67e-05	0.000315	CcSEcCtD
Imatinib—Oedema—Hydrocortisone—allergic rhinitis	4.64e-05	0.000313	CcSEcCtD
Imatinib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	4.64e-05	0.000313	CcSEcCtD
Imatinib—Convulsion—Triamcinolone—allergic rhinitis	4.64e-05	0.000312	CcSEcCtD
Imatinib—Tachycardia—Prednisolone—allergic rhinitis	4.64e-05	0.000312	CcSEcCtD
Imatinib—Convulsion—Methylprednisolone—allergic rhinitis	4.63e-05	0.000312	CcSEcCtD
Imatinib—Hypertension—Triamcinolone—allergic rhinitis	4.62e-05	0.000311	CcSEcCtD
Imatinib—Hypertension—Methylprednisolone—allergic rhinitis	4.61e-05	0.000311	CcSEcCtD
Imatinib—Infection—Hydrocortisone—allergic rhinitis	4.61e-05	0.000311	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisolone—allergic rhinitis	4.6e-05	0.000309	CcSEcCtD
Imatinib—LCK—TCR signaling—NFKB1—allergic rhinitis	4.59e-05	0.00246	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	4.58e-05	0.00245	CbGpPWpGaD
Imatinib—Shock—Hydrocortisone—allergic rhinitis	4.57e-05	0.000308	CcSEcCtD
Imatinib—Myalgia—Triamcinolone—allergic rhinitis	4.56e-05	0.000307	CcSEcCtD
Imatinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	4.55e-05	0.000307	CcSEcCtD
Imatinib—Arthralgia—Methylprednisolone—allergic rhinitis	4.55e-05	0.000306	CcSEcCtD
Imatinib—Myalgia—Methylprednisolone—allergic rhinitis	4.55e-05	0.000306	CcSEcCtD
Imatinib—Anxiety—Methylprednisolone—allergic rhinitis	4.53e-05	0.000305	CcSEcCtD
Imatinib—Tachycardia—Hydrocortisone—allergic rhinitis	4.53e-05	0.000305	CcSEcCtD
Imatinib—LCK—IL12-mediated signaling events—NFKB1—allergic rhinitis	4.53e-05	0.00242	CbGpPWpGaD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	4.52e-05	0.000304	CcSEcCtD
Imatinib—Skin disorder—Hydrocortisone—allergic rhinitis	4.51e-05	0.000304	CcSEcCtD
Imatinib—Ill-defined disorder—Betamethasone—allergic rhinitis	4.51e-05	0.000304	CcSEcCtD
Imatinib—Ill-defined disorder—Dexamethasone—allergic rhinitis	4.51e-05	0.000304	CcSEcCtD
Imatinib—Discomfort—Triamcinolone—allergic rhinitis	4.51e-05	0.000303	CcSEcCtD
Imatinib—Discomfort—Methylprednisolone—allergic rhinitis	4.5e-05	0.000303	CcSEcCtD
Imatinib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	4.49e-05	0.000302	CcSEcCtD
Imatinib—NTRK1—BDNF signaling pathway—NFKB1—allergic rhinitis	4.48e-05	0.0024	CbGpPWpGaD
Imatinib—LCK—Notch Signaling Pathway—NFKB1—allergic rhinitis	4.47e-05	0.00239	CbGpPWpGaD
Imatinib—Dry mouth—Triamcinolone—allergic rhinitis	4.46e-05	0.0003	CcSEcCtD
Imatinib—LCK—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	4.46e-05	0.00239	CbGpPWpGaD
Imatinib—Angioedema—Betamethasone—allergic rhinitis	4.44e-05	0.000299	CcSEcCtD
Imatinib—Angioedema—Dexamethasone—allergic rhinitis	4.44e-05	0.000299	CcSEcCtD
Imatinib—Anorexia—Hydrocortisone—allergic rhinitis	4.43e-05	0.000298	CcSEcCtD
Imatinib—Confusional state—Methylprednisolone—allergic rhinitis	4.4e-05	0.000296	CcSEcCtD
Imatinib—Malaise—Dexamethasone—allergic rhinitis	4.38e-05	0.000295	CcSEcCtD
Imatinib—Malaise—Betamethasone—allergic rhinitis	4.38e-05	0.000295	CcSEcCtD
Imatinib—Anaphylactic shock—Triamcinolone—allergic rhinitis	4.37e-05	0.000294	CcSEcCtD
Imatinib—Oedema—Triamcinolone—allergic rhinitis	4.37e-05	0.000294	CcSEcCtD
Imatinib—Vertigo—Betamethasone—allergic rhinitis	4.37e-05	0.000294	CcSEcCtD
Imatinib—Vertigo—Dexamethasone—allergic rhinitis	4.37e-05	0.000294	CcSEcCtD
Imatinib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	4.36e-05	0.000294	CcSEcCtD
Imatinib—Syncope—Betamethasone—allergic rhinitis	4.36e-05	0.000293	CcSEcCtD
Imatinib—Syncope—Dexamethasone—allergic rhinitis	4.36e-05	0.000293	CcSEcCtD
Imatinib—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	4.35e-05	0.00233	CbGpPWpGaD
Imatinib—Infection—Triamcinolone—allergic rhinitis	4.34e-05	0.000292	CcSEcCtD
Imatinib—Hypotension—Hydrocortisone—allergic rhinitis	4.34e-05	0.000292	CcSEcCtD
Imatinib—Infection—Methylprednisolone—allergic rhinitis	4.33e-05	0.000292	CcSEcCtD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	4.32e-05	0.00231	CbGpPWpGaD
Imatinib—Shock—Triamcinolone—allergic rhinitis	4.3e-05	0.00029	CcSEcCtD
Imatinib—Insomnia—Prednisolone—allergic rhinitis	4.3e-05	0.00029	CcSEcCtD
Imatinib—Shock—Methylprednisolone—allergic rhinitis	4.29e-05	0.000289	CcSEcCtD
Imatinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	4.28e-05	0.000288	CcSEcCtD
Imatinib—Loss of consciousness—Betamethasone—allergic rhinitis	4.27e-05	0.000288	CcSEcCtD
Imatinib—Loss of consciousness—Dexamethasone—allergic rhinitis	4.27e-05	0.000288	CcSEcCtD
Imatinib—Paraesthesia—Prednisolone—allergic rhinitis	4.27e-05	0.000287	CcSEcCtD
Imatinib—Tachycardia—Triamcinolone—allergic rhinitis	4.27e-05	0.000287	CcSEcCtD
Imatinib—Tachycardia—Methylprednisolone—allergic rhinitis	4.26e-05	0.000287	CcSEcCtD
Imatinib—Skin disorder—Methylprednisolone—allergic rhinitis	4.24e-05	0.000285	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	4.23e-05	0.000285	CcSEcCtD
Imatinib—Hyperhidrosis—Triamcinolone—allergic rhinitis	4.23e-05	0.000285	CcSEcCtD
Imatinib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	4.22e-05	0.000284	CcSEcCtD
Imatinib—Convulsion—Betamethasone—allergic rhinitis	4.21e-05	0.000284	CcSEcCtD
Imatinib—Convulsion—Dexamethasone—allergic rhinitis	4.21e-05	0.000284	CcSEcCtD
Imatinib—Insomnia—Hydrocortisone—allergic rhinitis	4.2e-05	0.000283	CcSEcCtD
Imatinib—Hypertension—Dexamethasone—allergic rhinitis	4.2e-05	0.000283	CcSEcCtD
Imatinib—Hypertension—Betamethasone—allergic rhinitis	4.2e-05	0.000283	CcSEcCtD
Imatinib—PDGFRA—Allograft Rejection—TGFB1—allergic rhinitis	4.19e-05	0.00224	CbGpPWpGaD
Imatinib—Paraesthesia—Hydrocortisone—allergic rhinitis	4.17e-05	0.000281	CcSEcCtD
Imatinib—ABL1—Regulation of Telomerase—TGFB1—allergic rhinitis	4.14e-05	0.00222	CbGpPWpGaD
Imatinib—Myalgia—Dexamethasone—allergic rhinitis	4.14e-05	0.000279	CcSEcCtD
Imatinib—Myalgia—Betamethasone—allergic rhinitis	4.14e-05	0.000279	CcSEcCtD
Imatinib—Anxiety—Dexamethasone—allergic rhinitis	4.12e-05	0.000278	CcSEcCtD
Imatinib—Anxiety—Betamethasone—allergic rhinitis	4.12e-05	0.000278	CcSEcCtD
Imatinib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	4.12e-05	0.0022	CbGpPWpGaD
Imatinib—Discomfort—Dexamethasone—allergic rhinitis	4.09e-05	0.000275	CcSEcCtD
Imatinib—Discomfort—Betamethasone—allergic rhinitis	4.09e-05	0.000275	CcSEcCtD
Imatinib—Dyspepsia—Hydrocortisone—allergic rhinitis	4.09e-05	0.000275	CcSEcCtD
Imatinib—Hypotension—Methylprednisolone—allergic rhinitis	4.08e-05	0.000274	CcSEcCtD
Imatinib—Pain—Prednisolone—allergic rhinitis	4.07e-05	0.000274	CcSEcCtD
Imatinib—KIT—Immune System—MS4A2—allergic rhinitis	4.05e-05	0.00217	CbGpPWpGaD
Imatinib—Decreased appetite—Hydrocortisone—allergic rhinitis	4.04e-05	0.000272	CcSEcCtD
Imatinib—LCK—CXCR4-mediated signaling events—CD4—allergic rhinitis	4.01e-05	0.00215	CbGpPWpGaD
Imatinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	4.01e-05	0.00027	CcSEcCtD
Imatinib—Fatigue—Hydrocortisone—allergic rhinitis	4e-05	0.00027	CcSEcCtD
Imatinib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	4e-05	0.00214	CbGpPWpGaD
Imatinib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	3.98e-05	0.000268	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	3.97e-05	0.000268	CcSEcCtD
Imatinib—Pain—Hydrocortisone—allergic rhinitis	3.97e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Betamethasone—allergic rhinitis	3.97e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—allergic rhinitis	3.97e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Dexamethasone—allergic rhinitis	3.97e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—allergic rhinitis	3.97e-05	0.000267	CcSEcCtD
Imatinib—NTRK1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	3.96e-05	0.00212	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—ICAM1—allergic rhinitis	3.96e-05	0.00212	CbGpPWpGaD
Imatinib—Insomnia—Triamcinolone—allergic rhinitis	3.95e-05	0.000266	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—allergic rhinitis	3.95e-05	0.000266	CcSEcCtD
Imatinib—Infection—Dexamethasone—allergic rhinitis	3.94e-05	0.000265	CcSEcCtD
Imatinib—Infection—Betamethasone—allergic rhinitis	3.94e-05	0.000265	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—allergic rhinitis	3.93e-05	0.000264	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—allergic rhinitis	3.92e-05	0.000264	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—allergic rhinitis	3.92e-05	0.000264	CcSEcCtD
Imatinib—Shock—Dexamethasone—allergic rhinitis	3.9e-05	0.000263	CcSEcCtD
Imatinib—Shock—Betamethasone—allergic rhinitis	3.9e-05	0.000263	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—allergic rhinitis	3.9e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—allergic rhinitis	3.89e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—allergic rhinitis	3.89e-05	0.000262	CcSEcCtD
Imatinib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	3.89e-05	0.00208	CbGpPWpGaD
Imatinib—Thrombocytopenia—Betamethasone—allergic rhinitis	3.88e-05	0.000262	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	3.88e-05	0.000262	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—allergic rhinitis	3.87e-05	0.000261	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—allergic rhinitis	3.87e-05	0.000261	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—allergic rhinitis	3.85e-05	0.000259	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—allergic rhinitis	3.84e-05	0.000259	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—allergic rhinitis	3.83e-05	0.000258	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—allergic rhinitis	3.83e-05	0.000258	CcSEcCtD
Imatinib—PDGFRA—Immune System—MS4A2—allergic rhinitis	3.83e-05	0.00205	CbGpPWpGaD
Imatinib—Feeling abnormal—Hydrocortisone—allergic rhinitis	3.83e-05	0.000258	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.8e-05	0.000256	CcSEcCtD
Imatinib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	3.78e-05	0.00203	CbGpPWpGaD
Imatinib—Anorexia—Betamethasone—allergic rhinitis	3.78e-05	0.000255	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—allergic rhinitis	3.78e-05	0.000255	CcSEcCtD
Imatinib—Urticaria—Prednisolone—allergic rhinitis	3.78e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—allergic rhinitis	3.77e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—allergic rhinitis	3.76e-05	0.000253	CcSEcCtD
Imatinib—Pain—Triamcinolone—allergic rhinitis	3.74e-05	0.000252	CcSEcCtD
Imatinib—Hypotension—Betamethasone—allergic rhinitis	3.71e-05	0.00025	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—allergic rhinitis	3.71e-05	0.00025	CcSEcCtD
Imatinib—LCK—Cytokine Signaling in Immune system—IL5—allergic rhinitis	3.69e-05	0.00198	CbGpPWpGaD
Imatinib—Urticaria—Hydrocortisone—allergic rhinitis	3.69e-05	0.000248	CcSEcCtD
Imatinib—Body temperature increased—Hydrocortisone—allergic rhinitis	3.67e-05	0.000247	CcSEcCtD
Imatinib—Abdominal pain—Hydrocortisone—allergic rhinitis	3.67e-05	0.000247	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	3.61e-05	0.000243	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	3.61e-05	0.000243	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—allergic rhinitis	3.6e-05	0.000243	CcSEcCtD
Imatinib—KIT—Adaptive Immune System—HLA-G—allergic rhinitis	3.6e-05	0.00193	CbGpPWpGaD
Imatinib—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.59e-05	0.000242	CcSEcCtD
Imatinib—Insomnia—Betamethasone—allergic rhinitis	3.59e-05	0.000242	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—allergic rhinitis	3.59e-05	0.000242	CcSEcCtD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.58e-05	0.00191	CbGpPWpGaD
Imatinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.57e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—allergic rhinitis	3.56e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—allergic rhinitis	3.56e-05	0.00024	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—allergic rhinitis	3.5e-05	0.000236	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—allergic rhinitis	3.49e-05	0.000235	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—allergic rhinitis	3.49e-05	0.000235	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—allergic rhinitis	3.47e-05	0.000234	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—allergic rhinitis	3.47e-05	0.000233	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—allergic rhinitis	3.46e-05	0.000233	CcSEcCtD
Imatinib—PDGFRB—Immune System—MS4A2—allergic rhinitis	3.45e-05	0.00185	CbGpPWpGaD
Imatinib—Abdominal pain—Methylprednisolone—allergic rhinitis	3.45e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—allergic rhinitis	3.45e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—allergic rhinitis	3.45e-05	0.000232	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	3.42e-05	0.000231	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	3.42e-05	0.000231	CcSEcCtD
Imatinib—Hypersensitivity—Hydrocortisone—allergic rhinitis	3.42e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Betamethasone—allergic rhinitis	3.42e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—allergic rhinitis	3.42e-05	0.00023	CcSEcCtD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—NFKB1—allergic rhinitis	3.41e-05	0.00183	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HLA-G—allergic rhinitis	3.41e-05	0.00183	CbGpPWpGaD
Imatinib—Pain—Dexamethasone—allergic rhinitis	3.39e-05	0.000228	CcSEcCtD
Imatinib—Pain—Betamethasone—allergic rhinitis	3.39e-05	0.000228	CcSEcCtD
Imatinib—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	3.39e-05	0.00181	CbGpPWpGaD
Imatinib—ABL1—Immune System—MS4A2—allergic rhinitis	3.36e-05	0.0018	CbGpPWpGaD
Imatinib—Asthenia—Hydrocortisone—allergic rhinitis	3.33e-05	0.000224	CcSEcCtD
Imatinib—NTRK1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	3.3e-05	0.00177	CbGpPWpGaD
Imatinib—Pruritus—Hydrocortisone—allergic rhinitis	3.29e-05	0.000221	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—allergic rhinitis	3.27e-05	0.00022	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—allergic rhinitis	3.27e-05	0.00022	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	3.24e-05	0.000218	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	3.24e-05	0.000218	CcSEcCtD
Imatinib—Hypersensitivity—Triamcinolone—allergic rhinitis	3.22e-05	0.000217	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—allergic rhinitis	3.21e-05	0.000216	CcSEcCtD
Imatinib—Diarrhoea—Hydrocortisone—allergic rhinitis	3.18e-05	0.000214	CcSEcCtD
Imatinib—Urticaria—Betamethasone—allergic rhinitis	3.15e-05	0.000212	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—allergic rhinitis	3.15e-05	0.000212	CcSEcCtD
Imatinib—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	3.15e-05	0.00168	CbGpPWpGaD
Imatinib—Dizziness—Prednisolone—allergic rhinitis	3.14e-05	0.000212	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—allergic rhinitis	3.14e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—allergic rhinitis	3.14e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—allergic rhinitis	3.14e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—allergic rhinitis	3.14e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—allergic rhinitis	3.14e-05	0.000211	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—allergic rhinitis	3.13e-05	0.000211	CcSEcCtD
Imatinib—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	3.1e-05	0.00166	CbGpPWpGaD
Imatinib—Pruritus—Triamcinolone—allergic rhinitis	3.09e-05	0.000208	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—allergic rhinitis	3.09e-05	0.000208	CcSEcCtD
Imatinib—LCK—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	3.08e-05	0.00165	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	3.08e-05	0.00165	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HLA-G—allergic rhinitis	3.07e-05	0.00164	CbGpPWpGaD
Imatinib—Dizziness—Hydrocortisone—allergic rhinitis	3.07e-05	0.000207	CcSEcCtD
Imatinib—NTRK1—Signaling Pathways—PTGDR2—allergic rhinitis	3.04e-05	0.00163	CbGpPWpGaD
Imatinib—Rash—Prednisolone—allergic rhinitis	3e-05	0.000202	CcSEcCtD
Imatinib—ABL1—Cell Cycle—TGFB1—allergic rhinitis	3e-05	0.0016	CbGpPWpGaD
Imatinib—Dermatitis—Prednisolone—allergic rhinitis	2.99e-05	0.000202	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—allergic rhinitis	2.98e-05	0.000201	CcSEcCtD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.98e-05	0.00159	CbGpPWpGaD
Imatinib—Headache—Prednisolone—allergic rhinitis	2.98e-05	0.000201	CcSEcCtD
Imatinib—Vomiting—Hydrocortisone—allergic rhinitis	2.95e-05	0.000199	CcSEcCtD
Imatinib—Rash—Hydrocortisone—allergic rhinitis	2.93e-05	0.000197	CcSEcCtD
Imatinib—Dermatitis—Hydrocortisone—allergic rhinitis	2.92e-05	0.000197	CcSEcCtD
Imatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	2.92e-05	0.00156	CbGpPWpGaD
Imatinib—Headache—Hydrocortisone—allergic rhinitis	2.91e-05	0.000196	CcSEcCtD
Imatinib—LCK—Host Interactions of HIV factors—CD4—allergic rhinitis	2.9e-05	0.00155	CbGpPWpGaD
Imatinib—Dizziness—Triamcinolone—allergic rhinitis	2.89e-05	0.000195	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—allergic rhinitis	2.88e-05	0.000194	CcSEcCtD
Imatinib—ABL2—Developmental Biology—NFKB1—allergic rhinitis	2.88e-05	0.00154	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	2.86e-05	0.00153	CbGpPWpGaD
Imatinib—Asthenia—Dexamethasone—allergic rhinitis	2.85e-05	0.000192	CcSEcCtD
Imatinib—Asthenia—Betamethasone—allergic rhinitis	2.85e-05	0.000192	CcSEcCtD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	2.84e-05	0.00152	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—NFKB1—allergic rhinitis	2.83e-05	0.00151	CbGpPWpGaD
Imatinib—Nausea—Prednisolone—allergic rhinitis	2.82e-05	0.00019	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—allergic rhinitis	2.81e-05	0.000189	CcSEcCtD
Imatinib—Pruritus—Betamethasone—allergic rhinitis	2.81e-05	0.000189	CcSEcCtD
Imatinib—ABL1—Hemostasis—IL5—allergic rhinitis	2.79e-05	0.00149	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	2.78e-05	0.00149	CbGpPWpGaD
Imatinib—Vomiting—Triamcinolone—allergic rhinitis	2.78e-05	0.000187	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—allergic rhinitis	2.77e-05	0.000187	CcSEcCtD
Imatinib—LCK—Immune System—MS4A2—allergic rhinitis	2.77e-05	0.00148	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	2.76e-05	0.00148	CbGpPWpGaD
Imatinib—Nausea—Hydrocortisone—allergic rhinitis	2.76e-05	0.000186	CcSEcCtD
Imatinib—Rash—Triamcinolone—allergic rhinitis	2.76e-05	0.000186	CcSEcCtD
Imatinib—ABL1—Developmental Biology—ADIPOQ—allergic rhinitis	2.76e-05	0.00148	CbGpPWpGaD
Imatinib—Dermatitis—Triamcinolone—allergic rhinitis	2.75e-05	0.000185	CcSEcCtD
Imatinib—Rash—Methylprednisolone—allergic rhinitis	2.75e-05	0.000185	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—allergic rhinitis	2.75e-05	0.000185	CcSEcCtD
Imatinib—Headache—Triamcinolone—allergic rhinitis	2.74e-05	0.000184	CcSEcCtD
Imatinib—Headache—Methylprednisolone—allergic rhinitis	2.73e-05	0.000184	CcSEcCtD
Imatinib—Diarrhoea—Dexamethasone—allergic rhinitis	2.71e-05	0.000183	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—allergic rhinitis	2.71e-05	0.000183	CcSEcCtD
Imatinib—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	2.67e-05	0.00143	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—NFKB1—allergic rhinitis	2.65e-05	0.00142	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	2.64e-05	0.00141	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	2.63e-05	0.00141	CbGpPWpGaD
Imatinib—Dizziness—Betamethasone—allergic rhinitis	2.62e-05	0.000177	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—allergic rhinitis	2.62e-05	0.000177	CcSEcCtD
Imatinib—Nausea—Triamcinolone—allergic rhinitis	2.6e-05	0.000175	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—allergic rhinitis	2.59e-05	0.000174	CcSEcCtD
Imatinib—NTRK1—Signaling by NGF—NFKB1—allergic rhinitis	2.59e-05	0.00139	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—NFKB1—allergic rhinitis	2.58e-05	0.00138	CbGpPWpGaD
Imatinib—Vomiting—Dexamethasone—allergic rhinitis	2.52e-05	0.00017	CcSEcCtD
Imatinib—Vomiting—Betamethasone—allergic rhinitis	2.52e-05	0.00017	CcSEcCtD
Imatinib—ALB—Folate Metabolism—NFKB1—allergic rhinitis	2.51e-05	0.00134	CbGpPWpGaD
Imatinib—Rash—Betamethasone—allergic rhinitis	2.5e-05	0.000168	CcSEcCtD
Imatinib—Rash—Dexamethasone—allergic rhinitis	2.5e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—allergic rhinitis	2.5e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—allergic rhinitis	2.5e-05	0.000168	CcSEcCtD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	2.49e-05	0.00133	CbGpPWpGaD
Imatinib—Headache—Betamethasone—allergic rhinitis	2.49e-05	0.000167	CcSEcCtD
Imatinib—Headache—Dexamethasone—allergic rhinitis	2.49e-05	0.000167	CcSEcCtD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.48e-05	0.00133	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—NFKB1—allergic rhinitis	2.48e-05	0.00133	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HLA-G—allergic rhinitis	2.47e-05	0.00132	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—NFKB1—allergic rhinitis	2.44e-05	0.00131	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—TGFB1—allergic rhinitis	2.4e-05	0.00129	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.38e-05	0.00128	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	2.37e-05	0.00127	CbGpPWpGaD
Imatinib—Nausea—Betamethasone—allergic rhinitis	2.36e-05	0.000159	CcSEcCtD
Imatinib—Nausea—Dexamethasone—allergic rhinitis	2.36e-05	0.000159	CcSEcCtD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	2.34e-05	0.00125	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CCL11—allergic rhinitis	2.3e-05	0.00123	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IL5—allergic rhinitis	2.3e-05	0.00123	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HLA-DQB1—allergic rhinitis	2.25e-05	0.0012	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PTGDR2—allergic rhinitis	2.22e-05	0.00119	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—NFKB1—allergic rhinitis	2.2e-05	0.00118	CbGpPWpGaD
Imatinib—KIT—Immune System—HLA-G—allergic rhinitis	2.18e-05	0.00117	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.18e-05	0.00117	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HLA-DQB1—allergic rhinitis	2.13e-05	0.00114	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PTGDR2—allergic rhinitis	2.11e-05	0.00113	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	2.09e-05	0.00112	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HLA-G—allergic rhinitis	2.07e-05	0.00111	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.07e-05	0.00111	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TGFB1—allergic rhinitis	2.06e-05	0.0011	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—SMAD3—allergic rhinitis	2e-05	0.00107	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	2e-05	0.00107	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	1.99e-05	0.00107	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	1.95e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.92e-05	0.00103	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	1.91e-05	0.00102	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PTGDR2—allergic rhinitis	1.9e-05	0.00102	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—NFKB1—allergic rhinitis	1.9e-05	0.00102	CbGpPWpGaD
Imatinib—LCK—HIV Infection—CD4—allergic rhinitis	1.89e-05	0.00101	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HLA-G—allergic rhinitis	1.86e-05	0.000997	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-G—allergic rhinitis	1.82e-05	0.000972	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.81e-05	0.000971	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—NFKB1—allergic rhinitis	1.8e-05	0.000961	CbGpPWpGaD
Imatinib—ALB—Platelet degranulation—TGFB1—allergic rhinitis	1.79e-05	0.000959	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—NFKB1—allergic rhinitis	1.76e-05	0.000944	CbGpPWpGaD
Imatinib—KIT—Immune System—IL5—allergic rhinitis	1.76e-05	0.000943	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CYSLTR1—allergic rhinitis	1.75e-05	0.000934	CbGpPWpGaD
Imatinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	1.71e-05	0.000913	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL11—allergic rhinitis	1.69e-05	0.000902	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TAC1—allergic rhinitis	1.67e-05	0.000895	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL5—allergic rhinitis	1.67e-05	0.000892	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CYSLTR1—allergic rhinitis	1.65e-05	0.000884	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—ICAM1—allergic rhinitis	1.64e-05	0.000878	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—NFKB1—allergic rhinitis	1.62e-05	0.000866	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL11—allergic rhinitis	1.6e-05	0.000854	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	1.59e-05	0.000848	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL5—allergic rhinitis	1.55e-05	0.000832	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—ICAM1—allergic rhinitis	1.55e-05	0.000831	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.54e-05	0.000824	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTGDR2—allergic rhinitis	1.52e-05	0.000815	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL5—allergic rhinitis	1.5e-05	0.000804	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-G—allergic rhinitis	1.5e-05	0.0008	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CYSLTR1—allergic rhinitis	1.49e-05	0.000797	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL5—allergic rhinitis	1.46e-05	0.000783	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL11—allergic rhinitis	1.44e-05	0.00077	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—ICAM1—allergic rhinitis	1.4e-05	0.000749	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL5—allergic rhinitis	1.37e-05	0.000736	CbGpPWpGaD
Imatinib—KIT—Immune System—HLA-DQB1—allergic rhinitis	1.36e-05	0.00073	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.33e-05	0.000711	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	1.32e-05	0.000707	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—NFKB1—allergic rhinitis	1.3e-05	0.000695	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HLA-DQB1—allergic rhinitis	1.29e-05	0.000691	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CD4—allergic rhinitis	1.26e-05	0.000672	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TAC1—allergic rhinitis	1.22e-05	0.000656	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD4—allergic rhinitis	1.21e-05	0.000645	CbGpPWpGaD
Imatinib—LCK—Immune System—IL5—allergic rhinitis	1.21e-05	0.000645	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CYSLTR1—allergic rhinitis	1.19e-05	0.000639	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CD4—allergic rhinitis	1.19e-05	0.000636	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HLA-DQB1—allergic rhinitis	1.16e-05	0.000622	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TAC1—allergic rhinitis	1.16e-05	0.000621	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL11—allergic rhinitis	1.15e-05	0.000618	CbGpPWpGaD
Imatinib—KIT—Disease—SMAD3—allergic rhinitis	1.14e-05	0.000613	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD4—allergic rhinitis	1.14e-05	0.000611	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL5—allergic rhinitis	1.14e-05	0.00061	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	1.13e-05	0.000607	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ICAM1—allergic rhinitis	1.12e-05	0.000601	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SMAD3—allergic rhinitis	1.09e-05	0.000585	CbGpPWpGaD
Imatinib—PDGFRA—Disease—SMAD3—allergic rhinitis	1.08e-05	0.00058	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—NFKB1—allergic rhinitis	1.08e-05	0.000579	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL5—allergic rhinitis	1.08e-05	0.000577	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CD4—allergic rhinitis	1.07e-05	0.000573	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TAC1—allergic rhinitis	1.04e-05	0.000559	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CD4—allergic rhinitis	1.04e-05	0.000559	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—NFKB1—allergic rhinitis	1.04e-05	0.000556	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD4—allergic rhinitis	1.03e-05	0.00055	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—NFKB1—allergic rhinitis	1.02e-05	0.000548	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	1.02e-05	0.000545	CbGpPWpGaD
Imatinib—KIT—Immune System—ICAM1—allergic rhinitis	9.95e-06	0.000533	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—NFKB1—allergic rhinitis	9.83e-06	0.000526	CbGpPWpGaD
Imatinib—PDGFRB—Disease—SMAD3—allergic rhinitis	9.76e-06	0.000522	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL5—allergic rhinitis	9.71e-06	0.00052	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ICAM1—allergic rhinitis	9.42e-06	0.000504	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	9.39e-06	0.000503	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-DQB1—allergic rhinitis	9.33e-06	0.0005	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NFKB1—allergic rhinitis	9.23e-06	0.000494	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	8.99e-06	0.000481	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—NFKB1—allergic rhinitis	8.86e-06	0.000474	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD4—allergic rhinitis	8.59e-06	0.00046	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ICAM1—allergic rhinitis	8.49e-06	0.000454	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	8.48e-06	0.000454	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TAC1—allergic rhinitis	8.38e-06	0.000449	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	8.32e-06	0.000445	CbGpPWpGaD
Imatinib—ABL1—Immune System—ICAM1—allergic rhinitis	8.27e-06	0.000443	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD4—allergic rhinitis	8.25e-06	0.000442	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SMAD3—allergic rhinitis	8.01e-06	0.000429	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	7.94e-06	0.000425	CbGpPWpGaD
Imatinib—LCK—Disease—SMAD3—allergic rhinitis	7.83e-06	0.000419	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.82e-06	0.000419	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL5—allergic rhinitis	7.79e-06	0.000417	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SMAD3—allergic rhinitis	7.59e-06	0.000406	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NFKB1—allergic rhinitis	7.4e-06	0.000396	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—allergic rhinitis	7.31e-06	0.000391	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NFKB1—allergic rhinitis	7.11e-06	0.000381	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—allergic rhinitis	6.92e-06	0.000371	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TGFB1—allergic rhinitis	6.85e-06	0.000367	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SMAD3—allergic rhinitis	6.83e-06	0.000366	CbGpPWpGaD
Imatinib—LCK—Immune System—ICAM1—allergic rhinitis	6.81e-06	0.000365	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—allergic rhinitis	6.75e-06	0.000361	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—allergic rhinitis	6.39e-06	0.000342	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKB1—allergic rhinitis	6.3e-06	0.000337	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—allergic rhinitis	6.24e-06	0.000334	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—allergic rhinitis	6.08e-06	0.000325	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKB1—allergic rhinitis	5.96e-06	0.000319	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—allergic rhinitis	5.76e-06	0.000308	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKB1—allergic rhinitis	5.56e-06	0.000298	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SMAD3—allergic rhinitis	5.48e-06	0.000294	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKB1—allergic rhinitis	5.37e-06	0.000288	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKB1—allergic rhinitis	5.24e-06	0.00028	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—allergic rhinitis	5e-06	0.000268	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—allergic rhinitis	4.85e-06	0.000259	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—allergic rhinitis	4.63e-06	0.000248	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—allergic rhinitis	4.62e-06	0.000247	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—allergic rhinitis	4.59e-06	0.000246	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKB1—allergic rhinitis	4.31e-06	0.000231	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—allergic rhinitis	4.13e-06	0.000221	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—allergic rhinitis	4.09e-06	0.000219	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKB1—allergic rhinitis	4.07e-06	0.000218	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKB1—allergic rhinitis	3.86e-06	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKB1—allergic rhinitis	3.47e-06	0.000186	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—allergic rhinitis	3.39e-06	0.000182	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—allergic rhinitis	3.32e-06	0.000178	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—allergic rhinitis	3.21e-06	0.000172	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—allergic rhinitis	2.89e-06	0.000155	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKB1—allergic rhinitis	2.79e-06	0.000149	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—allergic rhinitis	2.32e-06	0.000124	CbGpPWpGaD
